Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

Sprigg, N; Flaherty, K; Appleton, JP; Salman, RA; Bereczki, D; Beridze, M; Christensen, H; Ciccone, A; Collins, R; Czlonkowska, A; +19 more... Dineen, RA; Duley, L; Egea-Guerrero, JJ; England, TJ; Krishnan, K; Laska, AC; Law, ZK; Ozturk, S; Pocock, SJ; Roberts, I; Robinson, TG; Roffe, C; Seiffge, D; Scutt, P; Thanabalan, J; Werring, D; Whynes, D; Bath, PM; TICH-2 Investigators; (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(18)31033-X

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(18)31033-X

Abstract

Share

Download

Filename: Tranexamic-acid-for-hyperacute-primary-IntraCerebral-Haemorrhage-TICH-2.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar